Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Inspire Medical Systems Inc(INSP)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for INSP
10/09/2026: INSP (1-star) is a SELL. SELL for 3 days. Simulated Profits (34.68%). Updated daily EoD!
Inspire Medical Systems is a high-growth medical technology company that provides a unique implantable neurostimulation therapy for patients suffering from obstructive sleep apnea. The company has a leading position in the emerging segment of surgical sleep treatments, driven by strong clinical data and a growing network of trained physicians. Its main growth story centers on replacing non-adherent CPAP usage with a permanent device solution. However, the company faces risks related to high product costs, reimbursement uncertainty, and competition from entrenched CPAP providers. The stock is best suited for growth-oriented investors who are comfortable with the inherent volatility of medical device market adoption.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company is in an early-to-mid stage growth phase with high top-line expansion potential. |
| Momentum investor | Strong fit while signal remains positive | The stock often reacts strongly to growth milestones and expansion news, making it a potential target for momentum strategies. |
| Value investor | Weak fit | The stock typically trades at premium valuation multiples consistent with high-growth companies. |
| Dividend investor | Weak fit | The company does not pay dividends and focuses entirely on reinvesting for growth. |
| Low-risk investor | Weak fit | The stock exhibits significant volatility associated with its growth-stage and regulatory-sensitive business model. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | High-growth medtech stocks often experience sharp price swings based on earnings reports and market sentiment. |
| Valuation risk | Medium / high | Investors pay high multiples, leaving little room for error if growth slows down. |
| Competition risk (CPAP/Technology) | Medium | Established players like ResMed maintain a dominant share of the OSA market through lower-cost CPAP solutions. |
| Business quality | Medium / high | While the product is unique, the business model relies heavily on physician training and healthcare reimbursement infrastructure. |
| Dividend income | Low / none | There is no income component to the total return profile. |
| Execution risk | Medium | Scaling the number of active centers and maintaining patient throughput requires significant operational execution. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -4.78% | Avg. Invested days 37 | Today’s Advisory SELL |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/09/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.93B USD | Price to earnings Ratio 14.69 | 1Y Target Price 65 |
Price to earnings Ratio 14.69 | 1Y Target Price 65 | ||
Volume (30-day avg) 881.1K shares | Beta 0.73 | 52 Weeks Range 38.91 - 147.03 | Updated Date 10/08/2026 |
52 Weeks Range 38.91 - 147.03 | Updated Date 10/08/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.54 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Inspire Therapy System | Implantable neurostimulation device kits and related accessories. | Revenue comes primarily from selling the hardware components for the Inspire procedure. |
| Geography | Primary operations in the United States with growing footprints in international markets. | The vast majority of revenue is generated in the US, with international expansion serving as a secondary lever. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 14.69 | Forward PE 59.17 | Enterprise Value 1.70B | Price to Sales(TTM) 2.15 |
Enterprise Value 1.70B | Price to Sales(TTM) 2.15 | ||
Enterprise Value to Revenue 1.9 | Enterprise Value to EBITDA 19.78 | Shares Outstanding 28.91M | Shares Floating 23.28M |
Shares Outstanding 28.91M | Shares Floating 23.28M | ||
Percent Insiders 1.18 | Percent Institutions 130.23 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.